The Parallax View
Subscribe
Sign in
Home
Archive
About
Share this publication
The Parallax View
www.parallax.bio
Copy link
Twitter
Facebook
Email
The Parallax View
Finding unloved, undiscovered, and undervalued biotechs
By Parallax Advisers
· Launched a year ago
Subscribe
Learn more
By registering you agree to Substack's
Terms of Service
, our
Privacy Policy
, and our
Information Collection Notice
$CRTX | Cortexyme
A post-mortem and a look at what’s next
Mar 8
Cheatsheet: $AUPH | Aurinia
Recapping a year of buyout rumors
Feb 25
1
CD47: Eating Up Cancer and Biobucks
8,500 words on $TRIL $ALXO $IMAB $STTK $OSE $GILD
Sep 14, 2021
2
$BNTX | BioNTech: mRNA therapies beyond the COVID-19 vaccine
An exciting approach to auto-immune conditions published in Science shows the broad potential of future mRNA therapies
Feb 14
2
Most popular
The Biotech Investor's Resources
8
1
CD47: Eating Up Cancer and Biobucks
2
You've Been Targeted for Termination
3
$INFI | Infinity Pharma's bet on PI3K-γ
3
3
The State of Biotech Today
3
From Germophobe to Germophile
3
See all popular
New
Community
The State of Biotech Today
Our world in charts
Feb 9
3
The Biotech Investor's Resources
Use these to help make $XBI a better place
Jan 18
8
1
Q3 2021 13F Review + Composite Ticker List
Hi Subscriber, It’s been a busy past few weeks and we wanted to make sure we sent some goodies out to you as we wrap up a few more pieces on our end…
Dec 9, 2021
1
$GLUE | Monte Rosa Therapeutics
Drugging the undruggable, not redrugging the druggable
Oct 13, 2021
4
$TLIS | Talis, the Dark Horse of Point-of-Care Testing?
COVID-19 Variant & Flu POCT and the New Normal
Oct 6, 2021
1
Q2 2021 13F Review
Looking at portfolio changes for RA, Perceptive, Baker, OrbiMed, BVF, EcoR1, Redmile, Opaleye, Ghost Tree
Aug 20, 2021
3
$CCCC | C4 Therapeutics
2,700 words
Aug 13, 2021
2
Exclusive: $NRIX | Nurix Therapeutics
1,500 words
Aug 11, 2021
1
See all
Most popular
The Biotech Investor's Resources
8
1
CD47: Eating Up Cancer and Biobucks
2
You've Been Targeted for Termination
3
$INFI | Infinity Pharma's bet on PI3K-γ
3
3
The State of Biotech Today
3
From Germophobe to Germophile
3
See all popular
The Parallax View
Finding unloved, undiscovered, and undervalued biotechs
Subscribe
The Parallax View
Subscribe
About
Archive
Authors
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
